Gene · 2739
Papers2,767
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,767
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting Glyoxalase-1 Pathway with Natural Compounds: A Translational Strategy to Reduce Dicarbonyl Stress and Prevent Chronic Diseases. | Life (Basel) | 2026 | 42195377 | PubTator, text mining | PubMed |
| UCHL1-mediated deubiquitination of GLOD4 regulates mitochondrial homeostasis and PTC malignant progression via GLO1. | Mol Cell Biochem | 2026 | 42166003 | PubTator, text mining | PubMed |
| The AGE-RAGE-GLO1 Pathway in Glioma: A Systematic Review of Its Role in Tumour Biology and Therapy. | Curr Neuropharmacol | 2026 | 42163664 | PubTator, text mining | PubMed |
| Multitargeted Modulation of Skin Dullness by HNHT Formulation: Synergistic Inhibition of Melanogenesis, Glycation, and Lipofuscin Deposition. | J Cosmet Dermatol | 2026 | 42152519 | PubTator, text mining | PubMed |
| Increased Serum GLO-1 Levels Are Associated With the Pathophysiology and Development of Obsessive-Compulsive Disorder: Findings From a Case-Control Study. | Health Sci Rep | 2026 | 42147475 | PubTator, text mining | PubMed |
| Identification of novel candidate biomarkers for heart failure with preserved ejection fraction by the Olink proteomics platform. | Int J Cardiol Heart Vasc | 2026 | 42112507 | PubTator, text mining | PubMed |
| Structure-Based Discovery of Glyoxalase-I Inhibitors: Evaluating the Role of Active Site Water Molecules. | Drug Des Devel Ther | 2026 | 42057975 | PubTator, text mining | PubMed |
| Pharmaco-therapeutic modulation of the Glo1-Nrf2-RAGE functional network in chronic inflammation: polyphenols in the context of current anti-inflammatory therapy. | Inflammopharmacology | 2026 | 42053959 | PubTator, text mining | PubMed |
| Glyoxalase 1 promotes glioma progression by modulating Sox2 transcriptional networks in glioma stem-like cells. | Neuro Oncol | 2026 | 42011505 | PubTator, text mining | PubMed |
| Early Effects of Poly(I:C)-induced Neuroinflammation on Hippocampal Astrocyte Function and Glycolytic Metabolism. | J Neurochem | 2026 | 41968971 | PubTator, text mining | PubMed |
| PARK7 (DJ-1) indicates favorable prognosis and correlates with estrogen-receptor status and Nε-carboxymethyl-lysine (CML) accumulation in breast cancer. | Cancer Treat Res Commun | 2026 | 41935427 | PubTator, text mining | PubMed |
| Single-cell analysis of UNC13D-mediated immune and dedifferentiation heterogeneity in acute myeloid leukemia and development of a prognostic model. | Transl Cancer Res | 2026 | 41815171 | PubTator, text mining | PubMed |
| Advances in Targeting the AGEs-RAGE Pathway for the Treatment of Diabetic Kidney Disease. | Drug Des Devel Ther | 2026 | 41810125 | PubTator, text mining | PubMed |
| Redox imbalance and glutathione metabolism disruption drive neodymium - induced neurotoxicity in microglia. | Toxicology | 2026 | 41796712 | PubTator, text mining | PubMed |
| PGK1 Lactylation-Driven Self-Reinforcing Loop Orchestrates Glycolytic Reprogramming in FSP1+ Macrophages in Liver Fibrosis. | Research (Wash D C) | 2026 | 41783047 | PubTator, text mining | PubMed |
| Metabolic Mechanisms in Electroconvulsive Therapy for Schizophrenia: Role, Potential and Future Directions. | Int J Mol Sci | 2026 | 41751887 | PubTator, text mining | PubMed |
| Glyoxalase 2 Drives D-Lactate Oncometabolite Signaling to Promote Prostate Cancer Aggressiveness via FAK/Src Activation. | Antioxidants (Basel) | 2026 | 41750552 | PubTator, text mining | PubMed |
| Progress of Research on the Metabolic Regulation of Lactylation in Muscle Tissues and Its Disease Associations. | Biomolecules | 2026 | 41750282 | PubTator, text mining | PubMed |
| Dentofacial Malocclusion and Salivary Biomarkers in Asthmatic Patients: A Scoping Review. | Int Dent J | 2026 | 41740246 | PubTator, text mining | PubMed |
| Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutions. | Bioact Mater | 2026 | 41737633 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2739/papers?page=2